Literature DB >> 11905148

Memory effects of arginine vasopressin (AVP) and [7-9] fragment of its peptide chain in rats.

T Klimkiewicz1.   

Abstract

The effect of arginine vasopressin (AVP) and [7-9]-vasopressin on different memory types was examined in tests of active avoidance, passive avoidance and water maze after both intraventricular and subcutaneous injections. Results were compared with AVP and [7-9]AVP effects in open field and holeboard tests. Significant latency time elongation was observed after both icv and s.c. injections of AVP but not [7-9]AVP in the passive avoidance test. This effect was blocked by [beta-Mercapto-beta, beta-cyclopentanometyleno1-propionylo1-O-Et-Tyr2,Val4,Arg8]-vasopressin, an antagonist of V1 receptors. Injections of both peptides did not improve the performance in other performed tests including the open field test and the holeboard test. Therefore the results confirmed that AVP improves memory only in the passive avoidance test. This effect is probably mediated by central V1 receptors and is not induced by exploratory and locomotor activity impairment. Considering the above results together with the literature data, it seems that the most important fragment of AVP is [4-6] AVP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905148

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  2 in total

1.  Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.

Authors:  M Ludwig; V A Tobin; M F Callahan; E Papadaki; A Becker; M Engelmann; G Leng
Journal:  J Neuroendocrinol       Date:  2013-07       Impact factor: 3.627

2.  The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.

Authors:  Cassandra O Subiah; Musa V Mabandla; Alisa Phulukdaree; Anil A Chuturgoon; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2012-03-25       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.